{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:42:06Z","timestamp":1780602126021,"version":"3.54.1"},"reference-count":15,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2019]]},"DOI":"10.1620\/tjem.248.27","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T22:03:29Z","timestamp":1557525809000},"page":"27-29","source":"Crossref","is-referenced-by-count":24,"title":["Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw"],"prefix":"10.1620","volume":"248","author":[{"given":"Alessandro","family":"Allegra","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Innao","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolina","family":"Pulvirenti","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Musolino","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Allegra, A., Alonci, A., Penna, G., Granata, A., Nastro Siniscalchi, E., Oteri, G., Loddo, S., Teti, D., Cicciu, D., De Ponte, F.S. &amp; Musolino, C. (2010)  Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws.  <i>Acta Haematol<\/i>., 124, 79-85.","DOI":"10.1159\/000313787"},{"key":"2","unstructured":"Allegra, A., Innao, V., Allegra, A.G., Ettari, R., Pugliese, M., Pulvirenti, N. &amp; Musolino, C. (2019)  Role of the microbiota in hematologic malignancies.  <i>Neth. J. Med<\/i>., 77, 67-80."},{"key":"3","unstructured":"Allegra, A., Oteri, G., Nastro, E., Alonci, A., Bellomo, G., Del Fabro, V., Quartarone, E., Alati, C., De Ponte, F.S., Cicciu, D. &amp; Musolino, C. (2007)  Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells.  <i>Hematol. Oncol<\/i>., 25, 164-169."},{"key":"4","doi-asserted-by":"crossref","unstructured":"Alonci, A., Allegra, A., Bellomo, G., Quartarone, E., Oteri, G., Nastro, E., Cicciu, D., De Ponte, F.S. &amp; Musolino, C. (2007)  Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1.  <i>Leuk. Lymphoma<\/i>, 48, 1852-1854.","DOI":"10.1080\/10428190701509806"},{"key":"5","unstructured":"Carneiro, A., Falcao, M., Pirraco, A., Milheiro-Oliveira, P., Falcao-Reis, F. &amp; Soares, R. (2009)  Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cells.  <i>Exp. Eye Res<\/i>., 88, 522-527."},{"key":"6","unstructured":"Egloff-Juras, C., Gallois, A., Salleron, J., Massard, V., Dolivet, G., Guillet, J. &amp; Phulpin, B. (2018)  Denosumab-related osteonecrosis of the jaw: a retrospective study.  <i>J. Oral Pathol. Med<\/i>., 47, 66-70."},{"key":"7","unstructured":"Ge, Y.L., Zhang, X., Zhang, J.Y., Hou, L. &amp; Tian, R.H. (2009)  The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.  <i>Int. Immunopharmacol<\/i>., 9, 389-395."},{"key":"8","unstructured":"Girolami, I., Mancini, I., Simoni, A., Baldi, G.G., Simi, L., Campanacci, D., Beltrami, G., Scoccianti, G., D\u2019Arienzo, A., Capanna, R. &amp; Franchi, A. (2016)  Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.  <i>J. Clin. Pathol<\/i>., 69, 240-247."},{"key":"9","unstructured":"Khan, A.A., Morrison, A., Hanley, D.A., Felsenberg, D., McCauley, L.K., O\u2019Ryan, F., Reid, I.R., Ruggiero, S.L., Taguchi, A., Tetradis, S., Watts, N.B., Brandi, M.L., Peters, E., Guise, T., Eastell, R.,  et al. (2015)  Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.  <i>J. Bone Miner. Res<\/i>., 30, 3-23."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Musolino, C., Oteri, G., Allegra, A., Mania, M., D\u2019Ascola, A., Avenoso, A., Innao, V., Allegra, A.G. &amp; Campo, S. (2018)  Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.  <i>Ann. Hematol<\/i>., 97, 1259-1269.","DOI":"10.1007\/s00277-018-3296-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Nicolatou-Galitis, O., Kouri, M., Papadopoulou, E., Vardas, E., Galiti, D., Epstein, J.B., Elad, S., Campisi, G., Tsoukalas, N., Bektas-Kayhan, K., Tan, W., Body, J.J., Migliorati, C. &amp; Lalla, R.V.;  MASCC Bone Study Group  (2019)  Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.  <i>Support. Care Cancer<\/i>, 27, 383-394.","DOI":"10.1007\/s00520-018-4501-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Oteri, G., Allegra, A., Bellomo, G., Alonci, A., Nastro, E., Penna, G., Catalfamo, L., Cicciu, D., De Ponte, F.S. &amp; Musolino, C. (2008)  Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration.  <i>Cytokine<\/i>, 43, 103-104.","DOI":"10.1016\/j.cyto.2008.05.010"},{"key":"13","unstructured":"Ruggiero, S.L., Dodson, T.B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., O\u2019Ryan, F.;  American Association of Oral and Maxillofacial Surgeons  (2014)  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw: 2014 update.  <i>J. Oral Maxillofac. Surg<\/i>., 72, 1938-1956."},{"key":"14","unstructured":"Shibahara, T. (2019)  Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): a twist of fate in the bone.  <i>Tohoku J. Exp. Med<\/i>., 247, 75-86."},{"key":"15","unstructured":"Wood, J., Bonjean, K., Ruetz, S., Bellahcene, A., Devy, L., Foidart, J.M., Castronovo, V. &amp; Green, J.R. (2002)  Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.  <i>J. Pharmacol. Exp. Ther<\/i>., 302, 1055-1061."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/248\/1\/248_27\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T03:28:26Z","timestamp":1557545306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/248\/1\/248_27\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.248.27","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}